AnyCurb to provide ecobee SmartThermostat with every home purchase, bringing enhanced comfort and energy savings to their homebuyers

 AnyCurb will begin offering the ecobee SmartThermostat with voice control for free to homebuyers with the purchase of a home with an AnyCurb real estate agent.  The Data-Driven Real Estate Brokerage, which seeks to increase housing supply by making off-market homes attainable for homebuyers, announced the incentive program earlier this week. The goals of this program are to promote sustainability, … Continue reading AnyCurb to provide ecobee SmartThermostat with every home purchase, bringing enhanced comfort and energy savings to their homebuyers Continue Reading →

Kaskela Law LLC Announces Investigation of FirstEnergy Corp. (FE) and Encourages Long-Term FE Stockholders to Contact the Firm

Kaskela Law LLC announces that it is investigating FirstEnergy Corp. on behalf of the company’s stockholders.  The investigation seeks to determine whether the members of FirstEnergy’s board of directors breached their fiduciary duties to FirstEnergy and its stockholders.  Current FirstEnergy stockholders who purchased or acquired shares of the company’s stock prior to February 21, 2017 are encouraged to … Continue reading Kaskela Law LLC Announces Investigation of FirstEnergy Corp. (FE) and Encourages Long-Term FE Stockholders to Contact the Firm Continue Reading →

Osisko Metals Announces Closing of Fully-Subscribed $3 Million Non-Brokered Private Placement of Units

Osisko Metals Incorporated is pleased to announce that it has closed its previously-announced non-brokered private placement, pursuant to which the Corporation sold an aggregate of 7.5 million units of the Company (each, a “Unit“) at a price of $0.40 per Unit for aggregate gross proceeds of $3 million (the “Offering“). Each Unit consists of one common … Continue reading Osisko Metals Announces Closing of Fully-Subscribed $3 Million Non-Brokered Private Placement of Units Continue Reading →

Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results

Plus Therapeutics, Inc. announced financial and business results for its Second Quarter Fiscal Year 2020 ended June 30, 2020. Q2 2020 net loss was $1.8 million, or $0.45 per share, including payments to NanoTx LLC of $0.78 million. Net cash used in operating activities for the six months ended June 30, 2020 was approximately $2.9 million. … Continue reading Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results Continue Reading →

American Hotel Income Properties REIT LP Reports Second Quarter 2020 Results

American Hotel Income Properties REIT LP announced its financial results for the three and six months ended June 30, 2020.  “During the second quarter we successfully navigated what was likely the most severe hotel sector downturn in modern history, but we’re cautiously optimistic that the worst impacts of COVID-19 are now behind us,” said John O’Neill, CEO.  … Continue reading American Hotel Income Properties REIT LP Reports Second Quarter 2020 Results Continue Reading →

Kaskela Law LLC Announces Investigation of Karyopharm Therapeutics Inc. (KPTI) and Encourages Long-Term Stockholders to Contact the Firm

Kaskela Law LLC announces that it is investigating Karyopharm Therapeutics Inc. on behalf of the Company’s stockholders. The investigation seeks to determine whether the members of Karyopharm’s board of directors breached their fiduciary duties to the Company and its stockholders. Current Karyopharm stockholders who purchased or acquired shares of the Company’s stock prior to March 2, 2017 are encouraged … Continue reading Kaskela Law LLC Announces Investigation of Karyopharm Therapeutics Inc. (KPTI) and Encourages Long-Term Stockholders to Contact the Firm Continue Reading →

Seeking Justice for Pain Patients: Class Action Lawsuits Filed Against CVS, Walgreens and Costco for Refusal to Fill Opioid Prescriptions for Chronic Pain Patients

National class action lawsuits have been filed against the largest pharmacy chains in the country for discrimination in refusing to fill legitimate prescriptions for opioid medication.  Edith Fuog, a 48 yr. old Hispanic divorced mother , from Riverview, Fla., filed a nationwide class action lawsuit in the United States District Court for the District of Rhode Island located in Providence, R.I. against CVS … Continue reading Seeking Justice for Pain Patients: Class Action Lawsuits Filed Against CVS, Walgreens and Costco for Refusal to Fill Opioid Prescriptions for Chronic Pain Patients Continue Reading →

Paratek Pharmaceuticals Announces Second Quarter 2020 Total Revenue of $9.3 Million including NUZYRA® (omadacycline) Net Revenue of $8.1 Million

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use, today reported financial results and provided an update on corporate activities for the quarter ended June 30, 2020. “Demand for NUZYRA was strong in the … Continue reading Paratek Pharmaceuticals Announces Second Quarter 2020 Total Revenue of $9.3 Million including NUZYRA® (omadacycline) Net Revenue of $8.1 Million Continue Reading →

Would-Be Home Sellers Slow to Return Despite Buyer Demand

Newly pending sales remain well above last year’s level, according to Zillow’s Weekly Market Reporti. They fell for the second week running in week-over-week numbers, but other measures continue to show a fast-moving market that favors sellers, indicating the recent dip has more to do with a lack of inventory than waning interest from potential buyers. … Continue reading Would-Be Home Sellers Slow to Return Despite Buyer Demand Continue Reading →